Patients with gout who achieve a serum urate level lower than 6 mg/dL demonstrated a lower 5-year risk for cardiovascular events, according to data published in JAMA Internal Medicine.“Each gout flare ...

Researchers compared the efficacy of febuxostat for lowering serum urate levels among patients with gout with vs without chronic kidney disease.

Sobi® (STO: SOBI) and Arthrosi Therapeutics, Inc. (Arthrosi) announced today the completion of the acquisition of Arthrosi by Sobi.

New research indicates that a drug commonly prescribed for gout may also lower the risk of heart attack and stroke when taken ...

When you think of arthritis, achy, warm, swollen joints probably come to mind. These are indeed some of the most common symptoms of arthritis. But did you know there are actually over 100 different ...

Real-world study with over 100,000 patients shows that lowering blood urate levels with gout treatment reduces the risk of ...

NEW YORK CITY — Urate, the culprit of gout, affects the vasculature in multiple ways that can raise cardiovascular risk (CV) in an individual with gout, and following guidelines for gout treatment, ...

Research shows that a common gout medication may help reduce the risk of heart attack and stroke in people with gout.

Natalie McCormick, PhD, of the Rheumatology and Allergy Clinical Epidemiology Research (RACER) Center within the Division of Rheumatology in the Mass General Brigham Department of Medicine, is the ...

Gout is a type of inflammatory arthritis that causes pain and swelling in your joints, usually as flares that last for a week or two, and then resolve. Gout happens when the purines that are found in ...

A groundbreaking new study, led by experts at the University of Nottingham, has found that medicines used to treat gout can also reduce the risk of heart attack and stroke in people with gout. The new ...